Michael J. Shumski

Michael Shumski practices at Magruder Laser Vision in Orlando, Florida.

Michael Shumski's NPI, 1215225370, was assigned on July 11, 2011. Michael Shumski graduated from Perelman School of Medicine - Philadelphia in 2010. Michael Shumski holds Florida license ME127795.

Michael Shumski's primary practice is Magruder Laser Vision, at 120 E Par St Ste 2000, Orlando, FL 32804. The practice phone is (407) 843-5665.

Michael Shumski's primary practice is Magruder Laser Vision in Orlando, Florida. Dmand AI also links Michael Shumski to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Shumski practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Michael Shumski's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Michael Shumski is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Michael Shumski's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Michael Shumski treats.

CMS data shows 4,300 Medicare services from Michael Shumski across 17 procedure codes in 2024, for 691 Medicare patients. Medicare paid $493,569 for them. Every service was in an office.

CMS counts 691 Medicare patients who saw Michael Shumski in 2024. The largest group is 65 to 74, with 362 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael Shumski's median patient age at 73, with 61% women.

In 2024, Michael Shumski wrote 189 Medicare Part D claims for 155 patients. 19% of them were for generic drugs. CMS names the drug for 167 of them, across 2 drugs with 11 or more claims each, at $4,700 in total drug cost. In 2023, CMS named 189 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Michael Shumski for performance year 2024, reported as part of a group. Michael Shumski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 644 procedures of cataract surgery by Michael Shumski, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Michael Shumski, published from 2010 to 2018. Michael Shumski's most frequent co-authors are Kristin Marissa Galetta, MD, Amy Tara Waldman, MD and Robert A. Avery, DO.

CMS Open Payments shows 98 general payments to Michael Shumski from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. LENSAR, Inc. paid the most, $31,640. It also lists 2 research payments totaling $5,750 from 2021 to 2022.

Michael Shumski graduated from Perelman School of Medicine - Philadelphia in 2010.

Michael Shumski is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.